JPMorgan plans contingent interest autocallables tied to four stocks

By Wendy Van Sickle

Columbus, Ohio, Aug. 3 – JPMorgan Chase Financial Co. LLC plans to price autocallable contingent interest notes due Aug. 22, 2019 linked to the least performing of the common stocks of Merck & Co. Inc., Bristol-Myers Squibb Co., Pfizer Inc. and Eli Lilly and Co., according to a 424B2 filing with the Securities and Exchange Commission.

The notes are guaranteed by JPMorgan Chase & Co.

The notes will pay a contingent monthly coupon at an annual rate of at least 10% if each stock closes above its barrier, 55% of its initial level, on the observation date for that month. The exact coupon will be set at pricing.

The notes will be called at par if each stock closes at or above its initial level on any review date other than the first, second and final dates.

The payout at maturity will be par unless any stock finishes below its barrier, in which case investors will be fully exposed to any losses in the worst performing stock.

J.P. Morgan Securities LLC is the agent.

The notes will price on Aug. 19 settle on Aug. 24.

The Cusip number is 46646ETA0.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.